Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7

May 2006 Archive

Published on May 31, 2006 by Edgar Snyder
Vioxx Data Error

Thousands of lawsuits Merck has yet to face don’t look to be in their favor after admitting to an error in Vioxx’s test data. Merck’s admission supports claims by the drug’s critics that Vioxx can cause heart problems in a very short period of time.

Published on May 26, 2006 by Edgar Snyder
Emergency Room

Earlier this year, the Food and Drug Administration (FDA) decided that drugs used to treat attention deficit disorder (ADHD) did not need to carry a “black-box” warning. But according to the first national estimates on ADHD drugs, thousands of children and adults are sent to emergency rooms for accidental overdoses and side effects.

Published on May 19, 2006 by Edgar Snyder
Ketek

After conducting a safety review of the Sanofi-Aventis antibiotic Ketek, the Food and Drug Administration (FDA) panel has linked the drug to 12 cases of liver failure, including four deaths. They are urging for a bold warning to be placed on the label stating that “severe, life-threatening, and in some cases fatal” liver toxicity has occurred in patients.

Published on May 18, 2006 by Edgar Snyder
Arthritis Drugs

Rheumatoid arthritis drugs have been associated with serious infection risks for years, but researchers have now found a clear link to cancer.

Researchers at the Mayo Clinic studied existing clinical trial data on Johnson & Johnson's Remicade and Abbott Laboratories Humira and believe the incidences of infection and cancer may be higher than originally thought.

Published on May 16, 2006 by Edgar Snyder
Sad Teen

The Food and Drug Administration (FDA) announced in 2004 that antidepressants were linked to an increase in suicidal thoughts and behavior in children and young adults. Now, GlaxoSmithKline is sending doctors their own warning about an increased risk of suicide attempts in adults taking their antidepressant, Paxil.

Published on May 09, 2006 by Edgar Snyder
Off-label Prescriptions

When the Food and Drug Administration (FDA) approves a drug that does not mean it is safe for every kind of use. But findings show that one in seven prescriptions for common drugs are being used in ways that haven’t been approved by the FDA. A practice by doctors called “off-label” use.

Published on May 08, 2006 by Edgar Snyder
Child Medication

Doctors are prescribing a new class of antipsychotic drugs to treat mental illnesses in children. But there could be cause for concern—the drugs are only approved by the Food and Drug Administration (FDA) to treat adults with schizophrenia and bipolar disorder.

Published on May 05, 2006 by Edgar Snyder
ketek

The death of a 26-year-old construction worker who died from severe liver damage after taking the antibiotic Ketek has prompted a government investigation. An internal Food and Drug Administration (FDA) analysis reported ten cases of people sustaining liver failure after taking the antibiotic. Now documents have surfaced, including internal Aventis emails, piquing interest about a key clinical trial for Ketek, known as study 3014.

Published on May 03, 2006 by Edgar Snyder
Vioxx Research

Lawyers fighting Merck in Vioxx litigation now have proof that the drug is risky even if taken for less than 18 months. The Canadian Medical Association Journal published a study that found seniors who took Vioxx faced the highest risk of heart attack during the first two weeks on the drug.

Published on May 01, 2006 by Edgar Snyder
Celebrex

Sixteen months after halting advertising, Pfizer has revitalized their marketing campaign for the controversial painkiller, Celebrex. The goal is to increase sales of the drug which plummeted once the advertising stopped.

Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries